Uniform Mesh Structure Innovation: Tetra-Gel
Gellycle Co., Ltd.
Uniform Mesh Structure Innovation: Tetra-Gel
Tetra-Gel
New treatment methods expected in various medical fields.
A breakthrough in medical treatment, Tetra-Gel technology, developed in collaboration with Professor Takamasa Sakai from the University of Tokyo, promises a new horizon in medical applications.
This core technology enables the precise control of hydrogel properties, such as gelation time, degradation rate, stiffness, swelling degree, and pore size, overcoming previous limitations. The result is a versatile gel suitable for various medical applications.
Business Model
Explore Collaborative Development with Us
Partnership Opportunities
We invite companies to explore collaborative development opportunities using our Tetra-Gel technology. Our portfolio includes innovative concepts for gel artificial ligaments, tissue protectants, and adhesion prevention materials.
Potential applications range from hydrogel-based varicose vein treatments and slow-release gel capsules to nerve and fat regeneration scaffolds. By partnering with us, you can co-develop new products using our gel technology, which can then be sold as your company's own products. You can potentially address unmet medical needs. We have a track record of successful product launches and collaborations domestically and internationally.
Innovative Business Model
We are open to merging our technology with your ideas to create new development opportunities for joint projects. Let's co-create the future of gel medicine together.
* Transaction requirements will be discussed on an individual basis.
We invite companies to explore collaborative development opportunities using our Tetra-Gel technology. Our portfolio includes innovative concepts for gel artificial ligaments, tissue protectants, and adhesion prevention materials.
Potential applications range from hydrogel-based varicose vein treatments and slow-release gel capsules to nerve and fat regeneration scaffolds. By partnering with us, you can co-develop new products using our gel technology, which can then be sold as your company's own products. You can potentially address unmet medical needs. We have a track record of successful product launches and collaborations domestically and internationally.
Innovative Business Model
We are open to merging our technology with your ideas to create new development opportunities for joint projects. Let's co-create the future of gel medicine together.
* Transaction requirements will be discussed on an individual basis.
High-strength gel thread
Development Opportunity 1: Material for Artificial Ligaments
Our Tetra-Gel, capable of mimicking the composition of living tissues, has been developed into a material with the potential to serve as artificial ligaments.
This gel boosts mechanical strength three times that of biological ligaments. It maintains its properties even after extensive testing, mimicking the stresses of walking.
We are advancing non-clinical and clinical trials to bring this innovative solution to patients and are seeking partners for co-development.
This gel boosts mechanical strength three times that of biological ligaments. It maintains its properties even after extensive testing, mimicking the stresses of walking.
We are advancing non-clinical and clinical trials to bring this innovative solution to patients and are seeking partners for co-development.
Mechanism of Natural Tendon Regeneration
Development Opportunity 2: Tendon Healing and Adhesion Prevention
Traditional methods fall short of fully regenerating severed tendons. Our Tetra-Gel (hydrogel) barrier material, however, offers a novel solution by preventing external cell invasion and adhesion, thereby facilitating only intrinsic healing. We are progressing with both non-clinical and clinical trials to bring this technology to market and are looking for development partners to join us in this endeavor.
- URL (Japanese):https://gellycle.com/home
- URL (English):https://gellycle.com/home-en